Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Screening, Diagnosis, and Treatment

Nonalcoholic fatty liver disease (NAFLD), recently renamed metabolic dysfunction-associated steatotic liver disease (MASLD) affects ~70% of patients with type 2 diabetes (T2D), with ~20% showing signs of advanced liver fibrosis. Patients with T2D are at an increased risk of developing cirrhosis, liv...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciardullo, Stefano, Vergani, Michela, Perseghin, Gianluca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10488336/
https://www.ncbi.nlm.nih.gov/pubmed/37685664
http://dx.doi.org/10.3390/jcm12175597

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10488336/
https://www.ncbi.nlm.nih.gov/pubmed/37685664
http://dx.doi.org/10.3390/jcm12175597

Ejemplares similares